A Agilent Technologies Inc.

Agilent Technologies Presents Thought Leader Award to Bioengineering Researcher Rohit Bhargava of University of Illinois Cancer Center

Agilent Technologies Inc. (NYSE: A) today announced that Dr. Rohit Bhargava has received an Agilent Thought Leader Award in recognition of his pioneering work in the development of infrared spectroscopic imaging, and its application to life sciences research.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161212005186/en/

Agilent Thought Leader Award Winner Dr. Bhargava (Photo: Business Wire)

Agilent Thought Leader Award Winner Dr. Bhargava (Photo: Business Wire)

Dr. Bhargava is a founder professor of bioengineering at the University of Illinois Cancer Center, with laboratories also at the Beckman Institute for Advanced Science and Technology. He is also the founder and director of the Cancer Community at Illinois program, which will be renamed the Illinois Cancer Center in early 2017. His work in the advancement of novel chemical-imaging technologies includes developing infrared spectroscopy modalities and demonstrating how they apply to cancer detection, diagnosis and prognosis.

The Agilent Thought Leader Award, which includes funding and technology from Agilent, will enable Dr. Bhargava to develop new applications and software to facilitate infrared analysis of histological samples, in particular for cancer detection and diagnosis.

“We are grateful to Agilent for this support,” Dr. Bhargava said. “This relationship will allow us to work together to further establish the field of digital molecular pathology using infrared imaging.”

“We are delighted to support Dr. Bhargava’s research toward migrating infrared spectroscopic imaging from the lab to the clinic,” said Philip Binns, vice president and general manager of Agilent’s Spectroscopy and Vacuum Solutions Division. “Dr. Bhargava is well-positioned to lead the development of new biomedical applications of Agilent’s recently announced high-speed Laser Direct Infrared Imaging (LDIR) technology.”

The Agilent Thought Leader Award Program promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences, diagnostics and applied chemical markets. Information about previous award recipients is available on the Agilent Thought Leader Program webpage.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. Agilent generated revenue of $4.20 billion in fiscal 2016. The company employs about 12,500 people worldwide. Information about Agilent is available at www.agilent.com.

EN
12/12/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

6550-6569 S&P 500 Support Holding For Now After 5.5-months, the S&P 500 (SPX) has now failed to break and stay below the its 20-day MA. However, 6569 has been our level that needs to break in order for us to have confidence that a pullback has begun; SPX made a low of 6551 on Friday (less than 20 points or 0.3% from our 6569 level), meaning it was not a decisive breakdown (in time or price). As a result, our near-term bullish outlook since our 4/22/25 Compass remains intact, and it will stay t...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch